EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia

Dominique Bollino, Xinrong Ma, Kayla M Tighe, Andrea Casildo, Katharina Richard, Antonino Passaniti, Brandon Carter-Cooper, Erin T Strovel, Ashkan Emadi iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252313091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dominique Bollino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Institute, West Virginia University, Morgantown, WV 26506, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-bcl-2, Myeloid Cell Leukemia Sequence 1 Protein, Xenograft Model Antitumor Assays. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Servier Pharmacueticals, Servier Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our previous studies have demonstrated that pegcrisantaspase (PegC), a long-acting Erwinia asparaginase, synergizes with the BCL-2 inhibitor Venetoclax (Ven) in vitro and in vivo; however, the anti-leukemic activity of E. coli-derived asparaginases in combination with BCL-2 inhibition, and potential synergy with inhibitors of MCL-1, a key resistance factor of BCL-2 inhibition, has yet to be determined. Using a combination of human AML cells lines, primary samples, and in vivo xenograft mouse models, we established the anti-leukemic activity of the BCL-2 inhibitor S55746 and the MCL-1 inhibitor S63845, alone and in combination with the long-acting E. coli asparaginase calaspargase pegol-mknl (CalPegA). We report that CalPegA enhances the anti-leukemic effect of S55746 but does not impact the activity of S63845. The S55746-CalPegA combination inhibited protein synthesis and increased eIF4E/4EBP1 interaction, suggesting an inhibition of translational complex formation. These results support the clinical evaluation of CalPegA in combination with BCL-2 inhibition for AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProto-Oncogene Proteins c-bcl-2Myeloid Cell Leukemia Sequence 1 ProteinXenograft Model Antitumor AssaysAsparaginaseHumansAnimalsMiceCell Line, TumorDrug SynergismApoptosisPyrimidinesSulfonamidesThiophenesBridged Bicyclo Compounds, Heterocyclic

Stichwörter der Autor:innen

BCL-2MCL-1acute myeloid leukemiaasparaginase

Substanzen

Proto-Oncogene Proteins c-bcl-2Myeloid Cell Leukemia Sequence 1 ProteinAsparaginaseMCL1 protein, humanBCL2 protein, humanS63845venetoclaxPyrimidinesSulfonamidesThiophenes

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Institute, West Virginia University, Morgantown, WV 26506, USA.
  • Department of Medical Oncology, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
  • The Biology Department, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA.
  • Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

ORCID-Profile: Ashkan Emadi

Förderung

  • Servier Pharmacueticals
  • Servier Pharmaceuticals

Zitieren

APA

Bollino, D., Ma, X., Tighe, K. M., Casildo, A., Richard, K., Passaniti, A., Carter-Cooper, B., Strovel, E. T., & Emadi, A. (2024). Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313091

Vancouver

Bollino D, Ma X, Tighe KM, Casildo A, Richard K, Passaniti A, et al. Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313091

BibTeX
@article{Bollino2024,
  author = {Bollino, Dominique and Ma, Xinrong and Tighe, Kayla M and Casildo, Andrea and Richard, Katharina and Passaniti, Antonino and Carter-Cooper, Brandon and Strovel, Erin T and Emadi, Ashkan},
  title = {Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252313091}
}
Kostenlos starten →